Steve Ryder

Steve Ryder currently serves as a Member of the Board of Directors at MBX Biosciences, Inc. since January 2024 and as Chief Medical Officer at Rallybio since December 2018. Previous positions include Member of the Board of Directors at Reata Pharmaceuticals, Inc. from July 2022 to September 2023 and at Levo Therapeutics, Inc. from July 2019 to June 2022. Additionally, Steve Ryder held the role of Chief Development Officer at Alexion Pharmaceuticals, Inc. from July 2013 to December 2018. Steve Ryder earned a Doctor of Medicine (MD) degree from Mt Sinai School of Medicine.